Results 91 to 100 of about 1,314,107 (247)

Thermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fibre neuropathy from primary restless legs syndrome

open access: yes, 2010
This study aimed to assess thermal and mechanical perception and pain thresholds in primary idiopathic restless legs syndrome and secondary restless legs syndrome associated with small fibre neuropathy. Twenty-one patients (age: 53.4 +/- 8.4, n = 3, male)
Bachmann, Cornelius G.   +8 more
core   +1 more source

Restless legs syndrome — A review [PDF]

open access: yes, 1997
Restless legs syndrome is also known as Ekbom's syndrome, following his description in 1944, although the earliest known description dates from 1685 (Willis). It is a fairly common complaint which is not widely recognised by the medical profession.
Jones, H.J.S., Derodra, J.K.
core   +1 more source

Feasibility and usability of three consecutive nights with self‐applied, home polysomnography

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary In‐laboratory polysomnography, the gold‐standard for diagnosing sleep disorders, is resource‐demanding and not conducive to multiple night evaluations. Ambulatory polysomnography, especially when self‐applied, could be a viable alternative. This study aimed to assess the feasibility and reliability of self‐applied polysomnography over three ...
Dimitri Ferretti   +7 more
wiley   +1 more source

Normal regional brain iron concentration in restless legs syndrome measured by MRI

open access: yes, 2009
Susanne Knake1, Johannes T Heverhagen2, Katja Menzler1, Boris Keil2, Wolfgang H Oertel1, Karin Stiasny-Kolster11Department of Neurology, Center of Nervous Diseases, 2Department of Radiology, Philipps University, Marburg, GermanyAbstract: Using a
Susanne Knake   +3 more
core  

Subjects with restless legs syndrome.

open access: yes, 2015
ESS: Epworth Sleepiness Scale; IRLSGRS: International Restless-legs syndrome Study Group Scale; LEDD: L-Dopa Equivalent daily dose; LRRK2-PD: LRRK2 Parkinson disease subjects;MSLT: Multiple Sleep Latency Sleep Test; NA: Not applicable; NMC: Non ...
Manel Salamero (720269)   +18 more
core   +1 more source

Drugs Associated With Restless Legs Syndrome [PDF]

open access: yes, 2012
BACKGROUND: Several case reports have suggested that drugs could induce restless legs syndrome. However, no systematic review of this adverse drug reaction (ADR) in a pharmacovigilance database has been published.
Emmanuelle Bondon-Guitton   +9 more
core   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Venlafaxine-induced restless legs syndrome [PDF]

open access: yesDüşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2012
Restless legs syndrome is a movement disorder characterized by complaints of a strong urge to move the legs predominantly during the periods of rest or inactivity.
aysel milanlioglu
doaj  

Treatment of restless legs syndrome

open access: yesParkinsonism & Related Disorders, 2009
Restless legs syndrome (RLS) is one of the most common neurological disorders. It is characterised by an urge to move the legs accompanied by uncomfortable or unpleasant sensations. Symptoms occur predominantly at rest in the evening or at night, and they are alleviated by moving the affected extremity or by walking.
FERINI STRAMBI , LUIGI, Manconi M.
openaire   +4 more sources

Actigraphic assessment of periodic leg movements in patients with restless legs syndrome

open access: yes, 2013
The diagnosis of restless legs syndrome (RLS) relies upon diagnostic criteria which are based on history only, and dopaminergic treatment is not normally the first choice of treatment for all patients.
Cippà, M A   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy